Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078707053> ?p ?o ?g. }
- W2078707053 endingPage "15584" @default.
- W2078707053 startingPage "15576" @default.
- W2078707053 abstract "The p65 subunit of the inducible transcription factor NF-κB contains at least two strong transactivation domains (TADs) within its C terminus. The first domain, TA1, is contained within the last 30 amino acids of p65, whereas TA2 comprises the adjacent 90 amino acids. In this study, squelching experiments revealed that both TADs of p65, as well as the related subunit c-Rel, compete for the same cofactor(s) mediating transactivation. Both TADs of p65 share a common sequence motif, which is evolutionarily conserved and displays a remarkable degree of spatial organization when aligned on an α-helical surface. The functional importance of the common sequence motif was confirmed by deletion analysis of TA2. Within the conserved sequence motif, a 7-amino-acid repeat was noted. Idealized heptad repeats fused to the DNA binding domain of Gal4 were transcriptionally active, but only as multimers. Phosphorylation and transcriptional activity of a defined region within the TA2 domain was found to be stimulated by phorbol ester treatment of cells. In contrast, TA1 was constitutively phosphorylated, and its activity did not significantly respond to phorbol ester stimulation. The stimulatory effect of phorbol ester on transcription of the TA2 domain was completely blocked by the protein kinase C inhibitor. These data suggest that protein kinase C has a dual effect on NF-κB activity. It not only causes removal of IκB-α from cytoplasmic NF-κB but also augments the transactivation potential of activated nuclear NF-κB. The p65 subunit of the inducible transcription factor NF-κB contains at least two strong transactivation domains (TADs) within its C terminus. The first domain, TA1, is contained within the last 30 amino acids of p65, whereas TA2 comprises the adjacent 90 amino acids. In this study, squelching experiments revealed that both TADs of p65, as well as the related subunit c-Rel, compete for the same cofactor(s) mediating transactivation. Both TADs of p65 share a common sequence motif, which is evolutionarily conserved and displays a remarkable degree of spatial organization when aligned on an α-helical surface. The functional importance of the common sequence motif was confirmed by deletion analysis of TA2. Within the conserved sequence motif, a 7-amino-acid repeat was noted. Idealized heptad repeats fused to the DNA binding domain of Gal4 were transcriptionally active, but only as multimers. Phosphorylation and transcriptional activity of a defined region within the TA2 domain was found to be stimulated by phorbol ester treatment of cells. In contrast, TA1 was constitutively phosphorylated, and its activity did not significantly respond to phorbol ester stimulation. The stimulatory effect of phorbol ester on transcription of the TA2 domain was completely blocked by the protein kinase C inhibitor. These data suggest that protein kinase C has a dual effect on NF-κB activity. It not only causes removal of IκB-α from cytoplasmic NF-κB but also augments the transactivation potential of activated nuclear NF-κB." @default.
- W2078707053 created "2016-06-24" @default.
- W2078707053 creator A5004019719 @default.
- W2078707053 creator A5012807189 @default.
- W2078707053 creator A5058901224 @default.
- W2078707053 date "1995-06-01" @default.
- W2078707053 modified "2023-09-27" @default.
- W2078707053 title "Transactivation Domain 2 (TA2) of p65 NF-κB" @default.
- W2078707053 cites W135983215 @default.
- W2078707053 cites W1494657683 @default.
- W2078707053 cites W1502090830 @default.
- W2078707053 cites W1503524848 @default.
- W2078707053 cites W1542016002 @default.
- W2078707053 cites W1603650405 @default.
- W2078707053 cites W1958059146 @default.
- W2078707053 cites W1963289746 @default.
- W2078707053 cites W1964143820 @default.
- W2078707053 cites W1969419107 @default.
- W2078707053 cites W1970224035 @default.
- W2078707053 cites W1973912514 @default.
- W2078707053 cites W1980909735 @default.
- W2078707053 cites W1983668987 @default.
- W2078707053 cites W1984903682 @default.
- W2078707053 cites W1986473194 @default.
- W2078707053 cites W2000082154 @default.
- W2078707053 cites W2004636267 @default.
- W2078707053 cites W2006115758 @default.
- W2078707053 cites W2008608024 @default.
- W2078707053 cites W2013747720 @default.
- W2078707053 cites W2017922713 @default.
- W2078707053 cites W2019831987 @default.
- W2078707053 cites W2021052287 @default.
- W2078707053 cites W2033777731 @default.
- W2078707053 cites W2035278455 @default.
- W2078707053 cites W2037489737 @default.
- W2078707053 cites W2037705033 @default.
- W2078707053 cites W2040728185 @default.
- W2078707053 cites W2042688292 @default.
- W2078707053 cites W2047063509 @default.
- W2078707053 cites W2051831012 @default.
- W2078707053 cites W2053700118 @default.
- W2078707053 cites W2057093252 @default.
- W2078707053 cites W2061903251 @default.
- W2078707053 cites W2063500485 @default.
- W2078707053 cites W2068577315 @default.
- W2078707053 cites W2068584461 @default.
- W2078707053 cites W2073993982 @default.
- W2078707053 cites W2078856910 @default.
- W2078707053 cites W2087640316 @default.
- W2078707053 cites W2090509456 @default.
- W2078707053 cites W2117272440 @default.
- W2078707053 cites W2128584338 @default.
- W2078707053 cites W2149563853 @default.
- W2078707053 cites W2151892297 @default.
- W2078707053 cites W2164941141 @default.
- W2078707053 cites W4293247451 @default.
- W2078707053 cites W78369961 @default.
- W2078707053 doi "https://doi.org/10.1074/jbc.270.26.15576" @default.
- W2078707053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7797554" @default.
- W2078707053 hasPublicationYear "1995" @default.
- W2078707053 type Work @default.
- W2078707053 sameAs 2078707053 @default.
- W2078707053 citedByCount "158" @default.
- W2078707053 countsByYear W20787070532012 @default.
- W2078707053 countsByYear W20787070532013 @default.
- W2078707053 countsByYear W20787070532014 @default.
- W2078707053 countsByYear W20787070532015 @default.
- W2078707053 countsByYear W20787070532016 @default.
- W2078707053 countsByYear W20787070532017 @default.
- W2078707053 countsByYear W20787070532018 @default.
- W2078707053 countsByYear W20787070532019 @default.
- W2078707053 countsByYear W20787070532020 @default.
- W2078707053 crossrefType "journal-article" @default.
- W2078707053 hasAuthorship W2078707053A5004019719 @default.
- W2078707053 hasAuthorship W2078707053A5012807189 @default.
- W2078707053 hasAuthorship W2078707053A5058901224 @default.
- W2078707053 hasBestOaLocation W20787070531 @default.
- W2078707053 hasConcept C104292427 @default.
- W2078707053 hasConcept C104317684 @default.
- W2078707053 hasConcept C107824862 @default.
- W2078707053 hasConcept C117745874 @default.
- W2078707053 hasConcept C11960822 @default.
- W2078707053 hasConcept C1292079 @default.
- W2078707053 hasConcept C138885662 @default.
- W2078707053 hasConcept C153911025 @default.
- W2078707053 hasConcept C167625842 @default.
- W2078707053 hasConcept C179926584 @default.
- W2078707053 hasConcept C185592680 @default.
- W2078707053 hasConcept C2777730290 @default.
- W2078707053 hasConcept C41895202 @default.
- W2078707053 hasConcept C55493867 @default.
- W2078707053 hasConcept C62478195 @default.
- W2078707053 hasConcept C86339819 @default.
- W2078707053 hasConcept C86803240 @default.
- W2078707053 hasConcept C95444343 @default.
- W2078707053 hasConceptScore W2078707053C104292427 @default.
- W2078707053 hasConceptScore W2078707053C104317684 @default.
- W2078707053 hasConceptScore W2078707053C107824862 @default.